Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice

Min Wu(First People's Hospital of Chongqing), G. Prem‐Veer Reddy(Wayne State University), Tapas K. Kundu(Jawaharlal Nehru Centre for Advanced Scientific Research), Gregory Dyson(The Barbara Ann Karmanos Cancer Institute), Albert M. Levin(Henry Ford Hospital), Nilesh Gupta(Henry Ford Health System), Stephanie Kaypee(Tohoku University), Ho Jeong Kwon(Yonsei University), Mani Menon(Henry Ford Hospital), Mahadeva M. M. Swamy(G.S. Science, Arts And Commerce College), Indrani Datta(Henry Ford Health System), Sahn-Ho Kim(Henry Ford Hospital), Jing Li(Wayne State University)
Oncotarget
January 31, 2015
Cited by 18


Related Papers